References
- American College of Radiology. Breast imaging reporting and data system (BI-RADS), ultrasound. 4th ed. Reston, VA: American.
- Au-Yong IT, Evans AJ, Taneja S, et al (2009). Sonographic correlations with the new molecular classification of invasive breast cancer. Eur Radiol, 19, 2342-48. https://doi.org/10.1007/s00330-009-1418-2
- Bauer KR, Brown M, Cress RD (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-28. https://doi.org/10.1002/cncr.22618
- College of Radiology, 2003. Available at: http://www.acr. org/s_acr/sec.asp?CID=882&DID=14550, 2004
- Dogan BE, Gonzalez-Angulo AM, Gilcrease M, et al (2010). Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. Am J Roentgenol, 194, 1160-66. https://doi.org/10.2214/AJR.09.2355
- Dogan BE, Turnbull LW (2012). Imaging of triple-negative breast cancer. Ann Oncol, 23, 23-9. https://doi.org/10.1093/annonc/mds162
- Doreen C, Donovan A (2011). Triple negative breast cancer: therapeutic and prognostic implications. Asian Pac J Cancer Prev, 12, 2129-33.
- Gordon PB, Goldenberg SL (1995). Malignant breast masses detected only by ultrasound. A retrospective review. Cancer, 76, 626-30. https://doi.org/10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z
- Ildefonso C, Vazquez J, Guinea O, et al (2008). The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol, 136, 224-31. https://doi.org/10.1016/j.ejogrb.2006.10.025
- Irshad A, Leddy R, Pisano E, et al (2013). Assessing the role of ultrasound in predicting the biological behavior of breast cancer. Am J Roentgenol, 200, 284-90. https://doi.org/10.2214/AJR.12.8781
- Itoh A, Ueno E, Tohno E, et al (2006). Breast disease: clinical application of US elastography for diagnosis. Radiology, 239, 341-50. https://doi.org/10.1148/radiol.2391041676
- Japan Association of breast and thyroid sonology. guideline for breast ultrasound-Management and diagnosis. 2nd edn. Tokoy: Japanese 2008.
- Ko ES, Lee BH, Kim HA, et al (2010). Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol, 20, 1111-17. https://doi.org/10.1007/s00330-009-1656-3
- Kim SH, Seo BK, Lee J, et al (2008). Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta Oncol, 47, 1531-38. https://doi.org/10.1080/02841860801971413
- Krizmanich-Conniff KM, Paramagul C, Patterson SK, et al (2012). Triple receptor-negative breast cancer: imaging and clinical characteristics. Am J Roentgenol, 199, 458-64 https://doi.org/10.2214/AJR.10.6096
- Li B, Zhao X, Dai S-C, et al (2014). Associations between mammography and ultrasound imaging features and molecular characteristics of triple-negative breast cancer. Asian Pac J Cancer Prev, 15, 3555-9. https://doi.org/10.7314/APJCP.2014.15.8.3555
- Marquet KL, Wolter M, Handt S, et al (2002). Criteria of dignity in ultrasound mammography using a 10-MHz-transducer, also with regard to tumor size. Ultraschall Med, 23, 383-87 (in German). https://doi.org/10.1055/s-2002-36172
- Paik S, Shak S, Tang G, et al (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med, 351, 2817-26. https://doi.org/10.1056/NEJMoa041588
- Parajuly SS, Lan PY, Yun MB, et al (2012). Diagnostic potential of strain ratio measurement and a 5 point scoring method for detection of breast cancer: Chinese experience. Asian Pac J Cancer Prev, 13, 1447- 52. https://doi.org/10.7314/APJCP.2012.13.4.1447
- Parajuly SS, Lan PY, Yan L, et al (2010). Breast elastography: a hospital-based preliminary study in China. Asian Pac J Cancer Prev, 11, 809-14.
- Perou CM (2011). Molecular stratification of triple-negative breast cancers. Oncologist, 16, 61-70.
- Rizzatto GJ (2001). Towards a more sophisticated use of breast ultrasound. Eur Radiol, 11, 2425-35. https://doi.org/10.1007/s00330-001-1165-5
- Slamon DJ, Clark GM, Wong SG, et al (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-82. https://doi.org/10.1126/science.3798106
- Stavros AT, Thickman D, Rapp CL, et al (1995). Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology, 196, 123-34. https://doi.org/10.1148/radiology.196.1.7784555
- Taucher S, Rudas M, Mader RM, et al (2003). Do we need HER- 2/neu testing for all patients with primary breast carcinoma? Cancer, 98, 2547-53. https://doi.org/10.1002/cncr.11828
- Wang Y, Ikeda DM, Narasimhan B, et al (2008) Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology, 246, 367-75. https://doi.org/10.1148/radiol.2462070169
- Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P (2012). Sonographic features of triplenegative and non-triple-negative breast cancer. J Ultrasound Med, 31, 1531-41.
- Zonderland HM, Hermans J, Coerkamp EG (2000). Ultrasound variables and their prognostic value in a population of 1103 patients with 272 breast cancers. Eur Radiol, 10, 1562-68. https://doi.org/10.1007/s003300000585
Cited by
- Elastography for Breast Cancer Diagnosis: a Useful Tool for Small and BI-RADS 4 Lesions vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10739
- Role of Sonography in Predicting the Hormone Receptor Status of Breast Cancer: A Prospective Study pp.1552-5430, 2017, https://doi.org/10.1177/8756479317721663
- A New Challenge for Radiologists: Radiomics in Breast Cancer vol.2018, pp.2314-6141, 2018, https://doi.org/10.1155/2018/6120703